Atlas Trials

IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients

Clinical trial NCT01398085 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT01398085
Sponsor
University College, London
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Thyroid CancerThyroid Neoplasms
Start date
2012-06-26
Primary completion
2031-03-01
Enrollment
504

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.